The present study is the first to provide a comprehensive examination of expression levels and patterns of glutamate EAAT2 in the human hippocampus, subiculum, entorhinal cortex, and STG, and how this expression is altered in AD. This evidence concerns the gene SLC1A2 and Alzheimer disease.